Daisuke Sugiyama

Senior Lecturer

Nagoya University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daisuke Sugiyama is a Senior Lecturer at Nagoya City University in Japan. His research areas include cancer immunology and immunotherapy, particularly the role of regulatory T cells in tumor immunity and treatment responses. Recent articles have addressed topics such as the immune mechanisms induced by UVB irradiation and the effects of CSF1R signaling on tumor-associated macrophages.

Articles (9)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Akimichi Morita

JAPAN

View details

Atsushi Tanaka

JAPAN

View details

Kazuhiro Kakimi

Professor

Kindai University

JAPAN

View details

Sachiko Ito

Nagoya University

JAPAN

View details

Hiroyoshi Nishikawa

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daisuke Sugiyama

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

UVB Irradiation Expands Skin-Resident CD81+Foxp3+ Regulatory T Cells with a Highly Activated Phenotype

Coactivation of innate immune suppressive cells induces acquired resistance against combined TLR agonism and PD-1 blockade

Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages

Significance of regulatory T cells in cancer immunology and immunotherapy

Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab

Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia

CD4 + T cells are essential for the development of destructive thyroiditis induced by anti–PD-1 antibody in thyroglobulin-immunized mice

Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells

Collaborators (5)

Akimichi Morita

Atsushi Tanaka

Kazuhiro Kakimi

Sachiko Ito

Hiroyoshi Nishikawa

Make your next move.